1. 36LBA Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO. Issue 3 (September 2015) Authors: Pauligk, C.; Tannapfel, A.; Meiler, J.; Luley, K.B.; Kopp, H.G.; Homann, N.; Hofheinz, R.D.; Schmalenberg, H.; Probst, S.; Haag, G.M.; Egger, M.; Behringer, D.M.; Stoehlmacher, J.; Prasnikar, N.; Block, A.; Trojan, J.; Folprecht, G.; Pohl, M.; Schirmacher, P.; Al-Batran, S.E. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.23.06] INFLUENCE OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE AND HEART STRUCTURE IN THEIR OFFSPRING. (September 2017) Authors: Adamczak, M.; Dembowska, M.; Slabiak-Blaz, N.; Nieszporek, T.; Piecha, G.; Schirmacher, P.; Ritz, E.; Wiecek, A. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A rare case of recurrent malignant triton tumor in a male with NF1: Case report and mini-review. (2016) Authors: Aykut, B.; Wieczorek, K.; Schirmacher, P.; Büchler, M.W.; Hoffmann, K. Journal: International journal of surgery case reports Issue: Volume 21(2016) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.). (January 2017) Authors: von Laffert, M.; Schirmacher, P.; Warth, A.; Weichert, W.; Büttner, R.; Huber, R.M.; Wolf, J.; Griesinger, F.; Dietel, M.; Grohé, Ch. Journal: Lung cancer Issue: Volume 103(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis. Issue 8 (24th February 2014) Authors: Rupp, C.; Friedrich, K.; Folseraas, T.; Wannhoff, A.; Bode, K. A.; Weiss, K.‐H.; Schirmacher, P.; Sauer, P.; Stremmel, W.; Gotthardt, D. N. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 8(2014) Page Start: 873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma. Issue 1 (30th October 2018) Authors: Christopoulos, P.; Kirchner, M.; Bozorgmehr, F.; Endris, V.; Elsayed, M.; Budczies, J.; Ristau, J.; Penzel, R.; Herth, F.J.; Heussel, C.P.; Eichhorn, M.; Muley, T.; Meister, M.; Fischer, J.R.; Rieken, S.; Lasitschka, F.; Bischoff, H.; Sotillo, R.; Schirmacher, P.; Thomas, M. Journal: International journal of cancer Issue: Volume 144:Issue 1(2019) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Integrative analysis of methylation and copy number alteration reveals molecular subgroups of cholangiocarcinoma. (July 2016) Authors: Toth, R.; Goeppert, B.; Lipka, D.B.; Brocks, D.; Baehr, M.; Roessler, S.; Schirmacher, P.; Plass, C.; Weichenhan, D. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intrinsic subtypes and risk scores in ER+/HER2-Breast Cancer: a comparison of Prosigna and OncotypeDX risk categories with Ki67. (March 2017) Authors: Sinn, P.; Schneeweiss, A.; Endris, V.; Penzel, R.; Schirmacher, P.; Kirchner, M.; Stenzinger, A. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. (29th September 2016) Authors: Dieter, S. M.; Heining, C.; Agaimy, A.; Huebschmann, D.; Bonekamp, D.; Hutter, B.; Ehrenberg, K. R.; Fröhlich, M.; Schlesner, M.; Scholl, C.; Schlemmer, H.-P.; Wolf, S.; Mavratzas, A.; Jung, C. S.; Gröschel, S.; von Kalle, C.; Eils, R.; Brors, B.; Penzel, R.; Kriegsmann, M. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing. (October 2020) Authors: Christopoulos, P.; Kirchner, M.; Roeper, J.; Saalfeld, F.; Janning, M.; Bozorgmehr, F.; Magios, N.; Kazdal, D.; Volckmar, A.L.; Brückner, L.M.; Bochtler, T.; Kriegsmann, M.; Endris, V.; Penzel, R.; Kriegsmann, K.; Eichhorn, M.; Herth, F.J.F.; Heussel, C.P.; El Shafie, R.A.; Schneider, M.A. Journal: Lung cancer Issue: Volume 148(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗